Tissue-Based Testing
News on immunohistochemistry and other tissue-based testing methods.
The firm said that investors provided better-than-expected backing as the company anticipates growing use of its digital pathology platform in 2025.
Gestalt, Primaa Partner on AI-Based Testing for Skin Cancer
The firms said that they will integrate Primaa's skin cancer testing algorithms with Gestalt's PathFlow digital pathology software platform.
Proscia Nabs $50M in Funding to Support Commercialization of Digital Pathology Software
The firm said that the money will support work with OEM partners and the expanded development and integration of artificial intelligence-based tools.
The precision cancer business of PHC Holdings anticipates an increase in cancer cases and is expanding its digital pathology and immunohistochemistry instrument lineup.
Biocare Medical to Distribute Vitro Lab Testing Instrument in US
The instrument is used for advanced immunohistochemistry, in situ hybridization, and fluorescence in situ hybridization applications.